Funder: Gilead Sciences

Due Dates: January 30, 2026 (INCLUSION Global 2026 LOI) | April 3, 2026 (INCLUSION Global 2026 Full Application) | May 4, 2026 (RESONATE 2026 LOI) | May 29, 2026 (RESONATE 2026 Full Application)

Funding Amounts: INCLUSION Global: Up to $5,000,000 total program; typical award up to $500,000 (larger by discussion). RESONATE: Up to $4,000,000 total program. Award duration: 18–24 months.

Summary: Supports investigator-initiated and collaborative research in HIV prevention and management, antifungal therapies, and hepatitis B, C, and D to address unmet needs and improve patient outcomes.

Key Information: Proposals must align with specific RFP topics and eligibility; see program details below.